3 years ago

Cornea Derived MSCs Therapeutically Modulate Macrophage Immunophenotype And Angiogenic Function

Cornea Derived MSCs Therapeutically Modulate Macrophage Immunophenotype And Angiogenic Function
Khandaker N. Anwar, Asha Tadepalli, Alireza Mashaghi, Ali R. Djalilian, Samaneh Ghassemi, Gaurav Agnihotri, Peiman Hematti, Reza Dana, Ilham Putra, John A. Kink, Xiang Shen, Sofiya Reshetylo, Medi Eslani, Judy Hamouie
Macrophages are crucial drivers of inflammatory corneal neovascularization and thus are potential targets for immunomodulatory therapies. We hypothesized that therapeutic use of cornea derived mesenchymal stromal cells (cMSCs) may alter the function of macrophages. We found that cMSCs can modulate the phenotype and angiogenic function of macrophages. In vitro, cMSCs induce apoptosis of macrophages while preferentially promoting a distinct CD14hiCD16hiCD163hiCD206hi immunophenotype that has significantly reduced angiogenic effects based on in vitro angiogenesis assays. In vivo, application of cMSCs to murine corneas after injury leads to reduced macrophage infiltration and higher expression of CD206 in macrophages. Macrophages co-cultured (“educated”) by cMSCs express significantly higher levels of anti-angiogenic and anti-inflammatory factors compared to control macrophages. In vivo, injured corneas treated with cMSC-educated macrophages demonstrate significantly less neovascularization compared to corneas treated with control macrophages. Knocking down the expression of PEDF in cMSCs significantly abrogates its modulating effects on macrophages, as shown by the reduced rate of apoptosis, decreased expression of sFLT-1/PEDF, and increased expression of VEGF-A in the co-cultured macrophages. Similarly, cMSCs isolated from PEDF knockout mice are less effective compared to wild type cMSCs at inhibiting macrophage infiltration when applied to wild type corneas after injury. Overall, these results demonstrate that cMSCs therapeutically suppress the angiogenic capacity of macrophages and highlight the role of cMSC secreted PEDF in the modulation of macrophage phenotype and function. This article is protected by copyright. All rights reserved. In the setting of severe corneal injury or inflammation, chemokines and cytokines recruit inflammatory cells which in turn induce corneal angiogenesis via VEGF-A. Cell therapy with corneal derived MSCs could modulate this inflammation in part via PEDF by inducing apoptosis of macrophages and promoting a distinct macrophage immunophenotype (cMSC-educated macrophages - cMEMq) that secrete high levels of sFLT-1, PEDF, and TSG-6.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/stem.2781

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.